8ORW
 
 | | Crystal structure of human STING in complex with the agonist MD1203 | | Descriptor: | 9-[(1~{S},6~{R},8~{R},9~{R},10~{R},15~{R},17~{R},18~{R})-8-(6-aminopurin-9-yl)-9,18-bis(fluoranyl)-3,12-bis(oxidanyl)-3,12-bis(oxidanylidene)-2,4,7,11,13-pentaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecan-17-yl]-1~{H}-purin-6-one, Stimulator of interferon protein | | Authors: | Klima, M, Boura, E. | | Deposit date: | 2023-04-17 | | Release date: | 2023-12-20 | | Last modified: | 2024-04-17 | | Method: | X-RAY DIFFRACTION (2.95 Å) | | Cite: | Fluorinated cGAMP analogs, which act as STING agonists and are not cleavable by poxins: Structural basis of their function.
Structure, 32, 2024
|
|
8A5X
 | |
7ZV5
 | |
7ZV7
 | |
7ZV8
 | | Crystal structure of SARS Cov-2 main protease in complex with an inhibitor 58 | | Descriptor: | 3C-like proteinase nsp5, DIMETHYL SULFOXIDE, OCTANOIC ACID (CAPRYLIC ACID), ... | | Authors: | Rahimova, R, Di Micco, S, Marquez, J.A. | | Deposit date: | 2022-05-13 | | Release date: | 2022-12-07 | | Last modified: | 2024-02-07 | | Method: | X-RAY DIFFRACTION (1.937 Å) | | Cite: | Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2.
Eur.J.Med.Chem., 244, 2022
|
|
8UHP
 | | anti-Phosphohistidine Fab hSC44.ck.20.N32F with 3pTZA peptide | | Descriptor: | 1,2-ETHANEDIOL, 3pTza peptide, ACETATE ION, ... | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-09 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (1.98 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UHH
 | | anti-Phosphohistidine Fab hSC44.ck.elbow.20.N32F | | Descriptor: | 1,2-ETHANEDIOL, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, CHLORIDE ION, ... | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-09 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (1.84 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UIH
 | | anti-Phosphohistidine Fab hSC44.ck.20 with 3pTza peptide | | Descriptor: | 1,2-ETHANEDIOL, 3ptza peptide, hSC44.ck.20 Fab heavy chain, ... | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-10 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (1.85 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UHJ
 | | anti-Phosphohistidine Fab hSC44.ck.20.N32F | | Descriptor: | 1,2-ETHANEDIOL, SULFATE ION, hSC44.ck.20.N32F Fab light chain, ... | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-09 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (1.94 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UIO
 | | anti-Phosphohistidine Fab hSC44.ck | | Descriptor: | CITRIC ACID, hSC44.ck Fab heavy chain, hSC44.ck Fab light chain | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-10 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (1.75 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UHT
 | |
8UHN
 | | anti-Phosphohistidine Fab hSC44.ck.20.N32F with 3pHis peptide | | Descriptor: | 1,2-ETHANEDIOL, 3pHis peptide, ACETATE ION, ... | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-09 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (2.09 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UHS
 | | anti-Phosphohistidine Fab hSC44.ck.20.elbow bound to phosphate | | Descriptor: | 1,2-ETHANEDIOL, PHOSPHATE ION, hSC44.ck.20.elbow Fab heavy chain, ... | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-09 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (2.4 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UIT
 | | anti-Phosphohistidine Fab hSC44.ck with 3pHis peptide | | Descriptor: | 3pHis peptide, hSC44.ck Fab heavy chain, hSC44.ck Fab light chain | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-10 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (2.2 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UIG
 | | anti-Phosphohistidine Fab hSC44.ck.20 with 3pHis peptide | | Descriptor: | 3pHis peptide, hSC44.ck.20 Fab heavy chain, hSC44.ck.20 Fab light chain | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-10 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (1.9 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
8UJI
 | | anti-Phosphohistidine Fab hSC44.ck with 3pTza peptide | | Descriptor: | 1,2-ETHANEDIOL, 3-pTza peptide, hSC44.CK Fab heavy chain, ... | | Authors: | Kalagiri, R, Stanfield, R.L, Hunter, T, Wilson, I.A. | | Deposit date: | 2023-10-11 | | Release date: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody.
Biorxiv, 2024
|
|
